Product Information
MAPAP 500 MG/15 ML LIQUID is a generic product labeled by Major Pharmaceuticals, priced at $0.0192 per ML under NDC 00904584709. Its NADAC has been published 649 times since Nov 28, 2013.
Strength
500 mg/15mL
Manufacturer
Major PharmaceuticalsNDC
00904584709
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
7/2/2009
Price Statistics
The NADAC for MAPAP 500 MG/15 ML LIQUID has been published 649 times since Nov 28, 2013, and over the history we have for it it has risen 45.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0192 per ML |
|---|---|
| All-time high | $0.0194 (Jan 14, 2026) |
| All-time low | $0.0118 (Jun 17, 2015) |
| 52-week high | $0.0194 |
| 52-week low | $0.0172 |
| Median price | $0.0129 |
| Average price | $0.0134 |
| Largest weekly change | +18.3% (Oct 20, 2021) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MAPAP 500 MG/15 ML LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for MAPAP 500 MG/15 ML LIQUID, manufactured by Major Pharmaceuticals, is $0.0192 per ML (NDC 00904584709), effective Sep 30, 2026.
How has the price of MAPAP 500 MG/15 ML LIQUID changed over time?
Over the history we have for it, the NADAC for MAPAP 500 MG/15 ML LIQUID has risen 45.8%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MAPAP 500 MG/15 ML LIQUID?
Since Nov 28, 2013, the NADAC for MAPAP 500 MG/15 ML LIQUID has ranged from a low of $0.0118 (Jun 17, 2015) to a high of $0.0194 (Jan 14, 2026), with a median of $0.0129 per ML.
Are there cheaper alternatives to MAPAP 500 MG/15 ML LIQUID?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MAPAP 500 MG/15 ML LIQUID in a comparable dosage form, but none are currently priced below it.
Who manufactures MAPAP 500 MG/15 ML LIQUID?
MAPAP 500 MG/15 ML LIQUID (NDC 00904584709) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.